Published on 12 Feb 2022 on Guru Focus
Despite High Forecasts for 202
PFE, Financial) past the $100 billion revenue mark this year, nearly double what the pharma giant brought in for 2021, the company said during its...
Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT)
Merger activity declined last week with three new deals announced and five deals completed. Two o...
Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price
This post contains sponsored advertising content. This content is for informational purposes only...
Are Options Traders Betting on a Big Move in Arena (ARNA) Stock?
Investors in Arena Pharmaceuticals, Inc. ARNA need to pay close attention to the stock based on m...
Arena Pharma gains after report Pfizer deal will clear without HSR second request
Arena Pharmaceuticals (ARNA) rose 3.5% in after hours trading on a report that it's planned sale ...
John Dorfman: Why I think George Soros is wrong about Rivian
Dozens of car companies sprung up, and some were hot stocks at the time. Rivian could share the f...
Arena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in Focus
Arena Pharmaceuticals, Inc. ARNA incurred a loss of $2.54 per share for fourth-quarter 2021, wide...
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical...
Here's a roundup of top developments in the biotech space over the last 24 hours. Kodiak's Wet AM...
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead...
Biotech stock extended lower for a second straight week as risk aversion continued to pressure st...
Deals Are Booming, but Antitrust Scrutiny Has Deal Traders Worried
Merger targets Activision Blizzard Spirit Airlines and Zynga are trading well below their...
Despite High Forecasts for 202
PFE, Financial) past the $100 billion revenue mark this year, nearly double what the pharma giant...